Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.94T | 1.96T | 1.54T | 1.63T | 1.81T | 1.49T |
Gross Profit | 169.80B | 166.65B | 148.15B | 176.77B | 208.80B | 172.35B |
EBITDA | 78.39B | 106.02B | 102.24B | 96.16B | 120.80B | 92.91B |
Net Income | 54.37B | 34.08B | 29.79B | 20.33B | 45.02B | 24.41B |
Balance Sheet | ||||||
Total Assets | 2.44T | 2.38T | 2.17T | 1.89T | 2.13T | 2.04T |
Cash, Cash Equivalents and Short-Term Investments | 110.68B | 91.61B | 134.92B | 142.13B | 159.22B | 153.09B |
Total Debt | 709.59B | 593.10B | 603.16B | 533.56B | 608.71B | 629.48B |
Total Liabilities | 1.73T | 1.68T | 1.48T | 1.26T | 1.47T | 1.42T |
Stockholders Equity | 690.25B | 677.25B | 653.64B | 593.32B | 584.82B | 545.23B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.81B | -31.60B | -31.55B | -71.27B | -285.00M |
Operating Cash Flow | 0.00 | 58.89B | 51.35B | 45.16B | 6.89B | 78.44B |
Investing Cash Flow | 0.00 | -79.38B | -103.00B | -43.98B | -3.21B | -101.76B |
Financing Cash Flow | 0.00 | -13.21B | 32.92B | 3.47B | -5.05B | 41.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | €87.70B | 4.74 | 14.23% | 0.82% | 6.88% | 19.15% | |
80 Outperform | €123.70B | 13.57 | 6.29% | 3.41% | 17.91% | 37.76% | |
71 Outperform | $299.38B | 8.79 | 5.00% | 4.36% | 27.35% | 14.36% | |
70 Neutral | ¥174.11B | 11.04 | 6.29% | 3.52% | 3.95% | 5.88% | |
68 Neutral | $282.28B | 10.41 | 6.92% | 3.14% | -5.37% | -2.62% | |
65 Neutral | $90.10B | 24.18 | 6.35% | 1.54% | 13.48% | -24.74% | |
58 Neutral | $972.42B | 59.00 | 0.90% | 3.04% | 10.24% | -71.82% |